---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-019713"
form_type: "8-K"
ticker: "CHRS"
cik: "0001512762"
company_name: "Coherus Oncology, Inc."
filed_at: "2023-12-11T23:59:59+00:00"
generated_at: "2026-06-07T14:49:54.035586+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Coherus CFO Stilwell resigns; EVP McMichael named Interim CFO

## Summary
- McDavid Stilwell resigned as CFO and Principal Financial Officer, effective Dec 31, 2023, to pursue other opportunities.
- Bryan McMichael appointed Interim CFO and Principal Financial Officer, effective Dec 8, 2023.
- McMichael continues as EVP, Accounting, Corporate Controller and Principal Accounting Officer; previously at Gilead Sciences.
- No compensatory changes or grants in connection with the interim appointment.

## SEC filing metadata
- accession: 0001558370-23-019713
- form_type: 8-K
- ticker: CHRS
- cik: 0001512762
- company_name: Coherus Oncology, Inc.
- filed_at: 2023-12-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/0001558370-23-019713-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/chrs-20231209x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-019713
- JSON: https://secwatch.observer/filing/0001558370-23-019713.json
- Plain text: https://secwatch.observer/filing/0001558370-23-019713.txt

## Key facts
- Executive change
  Bryan McMichael was appointed as Interim Chief Financial Officer and Principal Financial Officer at Coherus Oncology, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer and Principal Financial Officer
  source text: The Board of Directors of the Company appointed Bryan McMichael, age 45, to serve as the Company’s Interim Chief Financial Officer and Principal Financial Officer effective December 8, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/0001558370-23-019713-index.htm
- Executive change
  McDavid Stilwell resigned as Chief Financial Officer, Principal Financial Officer at Coherus Oncology, Inc..
  - Action: resigned
  - Role: Chief Financial Officer, Principal Financial Officer
  source text: McDavid Stilwell notified the Company on December 7, 2023 of his resignation as Chief Financial Officer, Principal Financial Officer and employee of the Company in order to pursue other opportunities, in each case to be effective on December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/0001558370-23-019713-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.